TRUST-II: A Global Phase II Study for Taletrectinib inROS1fusion Positive Lung Cancer and Other Solid Tumors-MedSci.cn

TRUST-II: A Global Phase II Study for Taletrectinib inROS1fusion Positive Lung Cancer and Other Solid Tumors

Misako, N; Sugawara, S; Choi, CM; Okamoto, T; Yanagitani, N; Nosaki, K; Takahashi, T; Fujiwara, Y; Hayashi, H; Khoury, J; Nieva, J; Gabayan, AE; Raez, LE; Chen, H; Dimou, A; Pennell, N; Liu, G; Ou, SHI; Seto, T; Ohe, Y

JOURNAL OF THORACIC ONCOLOGY, 2022; 17 (9): S458

科室
- - 订阅+
  - 更多科室
工具
服务